Treatment of Locally Recurrent Epstein–barr Virus-Associated Nasopharyngeal Carcinoma Using the Anti-Viral Agent Cidofovir

Journal of Medical Virology - United States
doi 10.1002/jmv.21165
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley

Related search

Link of Nasopharyngeal Carcinoma and Epstein-Barr Virus

Biology, Medicine, & Natural Product Chemistry
2018English

Therapeutic Implications of Epstein–Barr Virus Infection for the Treatment of Nasopharyngeal Carcinoma

Therapeutics and Clinical Risk Management
2014English

A Novel Epstein-Barr Virus Subtype Associated With Nasopharyngeal Carcinoma Found in South China

Cancer Communications
Cancer ResearchOncology
2020English

Characterization of Epstein-Barr Virus miRNAome in Nasopharyngeal Carcinoma by Deep Sequencing

PLoS ONE
Multidisciplinary
2010English

Viral Proteins Associated With the Epstein-Barr Virus Transactivator, ZEBRA.

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
1992English

Epstein-Barr Virus DNA Load in Nasopharyngeal Brushings and Whole Blood in Nasopharyngeal Carcinoma Patients Before and After Treatment

Clinical Cancer Research
Cancer ResearchOncology
2013English

Twenty-Second Paterson Symposium: Epstein-Barr Virus and the Molecular Biology of Nasopharyngeal Carcinoma

British Journal of Cancer
Cancer ResearchOncology
1988English

Induction of CCL5 by Epstein-Barr Virus Infection Enhances Tumor Angiogenesis in Nasopharyngeal Carcinoma

Cancer Science
Cancer ResearchMedicineOncology
2018English

Epstein-Barr Virus-Encoded LMP1 Regulated Pim1 Kinase Expression Promotes Nasopharyngeal Carcinoma Cells Proliferation

OncoTargets and Therapy
OncologyPharmacology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy